Indication

Moraxella catarrhalis pneumonia

*Moraxella catarrhalis* pneumonia is a lower respiratory tract infection caused by the aerobic, gram-negative diplococcus *Moraxella catarrhalis*. Read more about Moraxella catarrhalis pneumonia

187 drugs 98 manufacturers

Advertisement

Drugs that treat it

Common Moraxella catarrhalis pneumonia therapies.

Showing 109–117 of 187 drugs

Filter & compare in the drug finder →Opens the drug finder with Moraxella catarrhalis pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Moraxella catarrhalis pneumonia.

*Moraxella catarrhalis* pneumonia is a lower respiratory tract infection caused by the aerobic, gram-negative diplococcus *Moraxella catarrhalis*.

While the organism frequently colonizes the human upper respiratory tract, pulmonary infection typically occurs as an opportunistic disease primarily affecting older adults, immunocompromised patients, or individuals with pre-existing cardiopulmonary disorders, particularly chronic obstructive pulmonary disease.

Pathophysiologically, the pathogen migrates into the distal airways and alveolar spaces, triggering localized mucosal inflammation and parenchymal consolidation.

Defining clinical features mirror other bacterial pneumonias, commonly presenting with productive cough, purulent sputum, fever, dyspnea, and localized crackles or infiltrate on chest imaging.

Personalize your experience

Follow Moraxella catarrhalis pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it